pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

9,360 catalysts · 3,189 8k filing · 2,032 grant · 1,000 device adverse event · 910 approval · 674 device 510k · 584 earnings

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 0 catalysts2026-08-12: 82 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 3 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-01-29×clear all
type
  • 8k filing3,189
  • grant2,032
  • device adverse event1,000
  • approval910
  • device 510k674
  • earnings584
device pma
508
  • device recall215
  • phase 2 completion172
  • recall167
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Feb 9, 2026

    50
    ›Feb 10, 2026device pma184d agoContamac, Ltd. — Optimum Infinite (tisilfocon A) Orthokeratology Lenses II (PMA)

    Product code: NUU. Advisory committee: OP. Decision: APPR

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoMedtronic Cardiac Rhythm Disease Management — CapSure Sense Lead 4574 CapSure Sense Lead 4073, 4074 Vitatron Crystalline Lead ICM09, ICM09B, ICM09JB Vitatron Excellen (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NVN. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoABBOTT MEDICAL — Deep Brain Stimulation (DBS) Implantable Pulse Generator (IPG) (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MHY. Advisory committee: NE. Decision: OK30

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoCooperVision, Inc. — Biofinity Sphere and Biofinity Toric (comfilcon A) Soft (Hydrophilic) Contact Lenses for Extended Wear (PMA supplement)

    Supplement type: 30-Day Notice. Product code: LPM. Advisory committee: OP. Decision: OK30

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoAbbott Vascular, Inc. — Perclose™ ProGlide Suture-Mediated Closure System; Perclose™ ProStyle Suture-Mediated Closure and Repair System (PMA supplement)

    Supplement type: 30-Day Notice. Product code: MGB. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoABBOTT MEDICAL — Spinal Cord Stimulation (SCS) Implantable Pulse Generator (IPG) (PMA supplement)

    Supplement type: 30-Day Notice. Product code: LGW. Advisory committee: NE. Decision: OK30

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoMedtronic, Inc. — Consulta CRT-P (C4TR01); Percepta Bipolar CRT-P (W1TR01); Percepta Quadripolar CRT-P (W4TR01); Serena Bipolar CRT-P (W1T (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: LWP. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoMedtronic, Inc. — CapSure Epicardial Pacing Lead (4965); CapSure Epicardial Pacing Lead (4968) (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: NVN. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoMedtronic, Inc. — HV Splitter/Adaptor kit 5019 IS-1 Connector Port Pin Plug Kit 6725 Sprint Quattro Lead 6935, 6947 Sprint Quattro Lead 69 (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: NVY. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoMedtronic, Inc. — Adapta, Versa, Sensia IPG (ADDR01, ADDR03, ADDR06, ADDRL1, ADSR03, ADVDD01, SED01, SES01, VEDR01); Adapta, Versa, Sensia (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: NVZ. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoMedtronic, Inc. — Attain OTW LV Lead; Consulta CRT-P; Percepta Bipolar CRT-P; Percepta Quadripolar CRT-P; Serena Bipolar CRT-P; Serena Qua (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: LWP. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoMedtronic, Inc. — Attain StarFix Lead (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: OJX. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoMedtronic, Inc. — Medtronic CoreValve™ Evolut™ PRO Transcatheter Aortic Valve; Medtronic Evolut™ PRO+ Transcatheter Aortic Valve; Medtroni (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: NPT. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoAlcon Research, LLC — UNIPURE SF6 Ophthalmic Gas in the UNIFEYE Gas Delivery System (PMA supplement)

    Supplement type: Real-Time Process. Product code: LPO. Advisory committee: OP. Decision: APPR

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoMedtronic, Inc. — CapSureFix Novus Lead (5076); CapSureFix Novus Lead (4076); Vitatron Crystalline ActFix Lead (ICF09B); Vitatron Crystall (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: NVN. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoMedtronic, Inc. — CapSure VDD-2 Lead 5038, 5038L, 5038S Service Kit-Pacemaker Repair Kit 5873C Vitatron Brilliant S+ VDD Lead IMW14Q, IMW1 (PMA supplement)Medtronic plc

    Supplement type: 30-Day Notice. Product code: NVZ. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 10, 2026device pma184d agoMedtronic Cardiac Rhythm Disease Management — CapSure SP Novus Lead 5092 CapSure SP Z Lead 5033 Vitatron Impulse II Lead IHP09, IHP09B, IHP09JB (PMA supplement)

    Supplement type: 30-Day Notice. Product code: NVN. Advisory committee: CV. Decision: OK30

    full page →fda device pma ↗
    ›Feb 10, 2026device recall184d agoOrthalign, Inc device recall (Cls II)

    Drill Plate, Ortho Dev. Trimax - Pegged, PREF Size 1 -5 REF:402566 component Lantern Knee System — Reason: Drill plates manufactured out of specification can result in a bone cut in excess 00800"(2.8448mm) — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 10, 2026device recall184d agoOrthalign, Inc device recall (Cls II)

    Drill Plate, Ortho Dev. Trimax - Pegged, PREF Size 6-7 REF:402567 component Lantern Knee System — Reason: Drill plates manufactured out of specification can result in a bone cut in excess 00800"(2.8448mm) — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 10, 2026device recall184d agoLeMaitre Vascular, Inc. device recall (Cls II)LEMAITRE VASCULAR INC

    Artegraft Vascular Graft; REF#: AG740; — Reason: Labeling mix-up resulting in the incorrect lot outer packaging of product. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 10, 2026device recall184d agoBoston Scientific Corporation device recall (Cls II)BOSTON SCIENTIFIC CORP

    EndoVive Safety PEG Kit; Outer Box Material Number (UPN): M00509001; Inner Box Material Number (UPN): M00509000; — Reason: Recall of kits which utilized ChloraPrep Triple Swabsticks from BD. Open or compromised seals on the sterile swabstick packaging, which could result in loss of sterility or drying of the antiseptic solution. This component is placed outside of the sterile barrier of the tray manufactured by Boston Scientific, which contains the majority of the kit components. As such, inclusion of the affected ChloraPrep Triple Swabsticks does not degrade the integrity of the other components within the PEG kit. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 10, 2026device recall184d agoMedline Industries, LP device recall (Cls II)

    Puracol and Puracol Plus Collagen Wound Dressings: MSC8522 DRESSING,COLLAGEN,PURACOL,STRL,2" X 2" MSC8622EP DRESSING,COLLAGEN,PURACOL PLUS, 2X2.2" — Reason: Elevated endotoxin levels identified in affected lots. Issue may elicit strong inflammatory response if used, including local tissue irritation, delayed wound healing, or systemic effects such as fever and hypotension. In severe cases, septic shock may result. — Status: Ongoing

    full page →fda device recalls ↗
    ›Feb 10, 2026grant184d agoNORTH DAKOTA STATE UNIVERSITY — Targeting CLEC-2/podoplanin as a therapeutic strategy for pancreatic cancer

    GM grant. $224,737. PI: Elisabetta Liverani

    full page →nih reporter ↗
    ›Feb 10, 2026grant184d agoUNIVERSITY OF WEST FLORIDA — NeuroNauts Scholars

    NS grant. $110,118. PI: RODNEY P GUTTMANN

    full page →nih reporter ↗
    ›Feb 10, 2026grant184d agoKEYSTONE SYMPOSIA — Myeloid Cells: Functional Heterogeneity with Therapeutic Promise

    AI grant. $16,500. PI: TERRY L. SHEPPARD

    full page →nih reporter ↗
    ›Feb 10, 2026grant184d agoUNIVERSITY OF CONNECTICUT SCH OF MED/DNT — RpoS-independent gene regulation by the Borrelia burgdorferi Fur ortholog BosR

    AI grant. $457,875. PI: MELISSA J CAIMANO

    full page →nih reporter ↗
    ›Feb 10, 2026grant184d agoUT SOUTHWESTERN MEDICAL CENTER — Defining virulence factor functions using minimal pathogen genomes

    AI grant. $596,318. PI: Neal Mathew Alto

    full page →nih reporter ↗
    ›Feb 10, 2026grant184d agoUNIVERSITY OF IOWA — Impact of whole-body radiation exposure on pathogen-specific memory CD8 T cellsUniversity of Iowa

    AI grant. $649,484. PI: VLADIMIR P BADOVINAC

    full page →nih reporter ↗
    ›Feb 10, 2026grant184d agoUNIVERSITY OF COLORADO DENVER — Extracellular-Vesicle Derived Biomarkers in Diabetic NeuropathyUniversity of Colorado Denver

    DK grant. $117,000. PI: VERA FRIDMAN

    full page →nih reporter ↗
    ›Feb 10, 2026grant184d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Applying novel tools to parse Plasmodium vivax relapses in clinical trials

    AI grant. $190,825. PI: Jessica Lin

    full page →nih reporter ↗
    ›Feb 10, 2026grant184d agoHARVARD UNIVERSITY — Elucidating Biomolecular Dynamics using Magnetic Resonance Augmented by Machi...

    GM grant. $142,182. PI: Kushal Seetharam

    full page →nih reporter ↗
    ›Feb 10, 2026grant184d agoINDIANA UNIVERSITY INDIANAPOLIS — Dysregulation of humoral immunity following Plasmodium infection

    AI grant. $790,946. PI: Nathan Schmidt

    full page →nih reporter ↗
    ›Feb 10, 2026grant184d agoTEMPLE UNIV OF THE COMMONWEALTH — Lung-on-a-Chip and Spatial Transcriptomics to Define Eicosanoid Roles in Muco...

    AI grant. $435,875. PI: Vincent Tam

    full page →nih reporter ↗
    ›Feb 10, 2026grant184d agoUNIVERSITY OF PITTSBURGH AT PITTSBURGH — Deciphering HIV-1 Resistance Pathways against Capsid Inhibitors in vitro and ...

    AI grant. $790,847. PI: Zandrea Ambrose

    full page →nih reporter ↗
    ›Feb 10, 2026grant184d agoUNIVERSITY OF CALIFORNIA-IRVINE — Molecular Architecture of the Vaccinia virus factory

    AI grant. $235,500. PI: Paul D Gershon

    full page →nih reporter ↗
    ›Feb 10, 2026grant184d agoTUFTS UNIVERSITY BOSTON — Spatial multi-omics to predict granuloma trajectory and bacterial restriction...

    AI grant. $490,704. PI: Amanda Martinot

    full page →nih reporter ↗
    ›Feb 10, 2026grant184d agoUNIVERSITY OF VIRGINIA — Decoding Human Immune Programs in Sequential Rhinovirus InfectionsUniversity of Virginia

    AI grant. $444,125. PI: Judith A Woodfolk

    full page →nih reporter ↗
    ›Feb 10, 2026grant184d agoSALK INSTITUTE FOR BIOLOGICAL STUDIES — Molecular Pathways Leading to Drug Resistance in HIV-1 Integrase

    AI grant. $515,625. PI: Dmitry Lyumkis

    full page →nih reporter ↗
    ›Feb 10, 2026grant184d agoST. JUDE CHILDREN'S RESEARCH HOSPITAL — Dissecting a Novel Pathway for Degradative Endosome Generation during Rapid S...

    GM grant. $462,500. PI: Yuuta Imoto

    full page →nih reporter ↗
    ›Feb 10, 2026grant184d agoFEINSTEIN INSTITUTE FOR MEDICAL RESEARCH — Maturation and maintenance of the germinal center niche

    AI grant. $460,625. PI: YONG-RUI ZOU

    full page →nih reporter ↗
    ›Feb 10, 2026grant184d agoUNIVERSITY OF WISCONSIN-MADISON — Pathophysiology of Severe Yellow Fever

    AI grant. $729,189. PI: Adam Lee Bailey

    full page →nih reporter ↗
    ›Feb 10, 2026grant184d agoBARUCH S. BLUMBERG INSTITUTE — Identification of cellular functions involved in Hepatitis B Virus infection ...

    AI grant. $195,750. PI: Liudi Tang

    full page →nih reporter ↗
    ›Feb 10, 2026grant184d agoNORTHWESTERN UNIVERSITY AT CHICAGO — Reengineering Fibroblast Growth Factor 2 to Address Allograft VasculopathyNorthwestern University

    AI grant. $440,000. PI: SATISH N NADIG

    full page →nih reporter ↗
    ›Feb 10, 2026grant184d agoUNIVERSITY OF NEBRASKA LINCOLN — Regeneration of lymphatic valve after injury

    GM grant. $160,566. PI: Mohammad Razavi Rizi

    full page →nih reporter ↗
    ›Feb 11, 2026approval183d agoGLATIRAMER ACETATE — FDA approvalGLATIRAMER ACETATE

    Sponsor: HYBIO. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →GLATIRAMER ACETATE →fda approvals ↗
    ›Feb 11, 2026approval183d agoCAMCEVI KIT (LEUPROLIDE MESYLATE) — FDA approvalForesee Pharmaceuticals Co Ltd

    Sponsor: ACCORD. Form: EMULSION. Route: SUBCUTANEOUS

    full page →fda approvals ↗
    ›Feb 11, 2026approval183d agoNARCAN (NALOXONE HYDROCHLORIDE) — FDA approvalEmergent Devices Inc

    Sponsor: EMERGENT. Form: SPRAY, METERED. Route: NASAL

    full page →fda approvals ↗
    ›Feb 11, 2026approval183d agoAUBAGIO (TERIFLUNOMIDE) — FDA approvalteriflunomide

    Sponsor: SANOFI AVENTIS US. Form: TABLET. Route: ORAL

    full page →teriflunomide →fda approvals ↗
    ›Feb 11, 2026approval183d agoGLATIRAMER ACETATE — FDA approvalGLATIRAMER ACETATE

    Sponsor: HYBIO. Form: INJECTABLE. Route: SUBCUTANEOUS

    full page →GLATIRAMER ACETATE →fda approvals ↗
    ›Feb 11, 2026approval183d agoPAXLOVID (COPACKAGED) (NIRMATRELVIR) — FDA approvalPAXLOVID (COPACKAGED)

    Sponsor: PFIZER. Form: TABLET. Route: ORAL

    full page →PAXLOVID (COPACKAGED) →fda approvals ↗
    ← prev
    page 16 of 188
    next →
    $MDT90.76+0.09%
    $MDT90.76+0.09%
    $MDT90.76+0.09%
    $MDT90.76+0.09%
    $MDT90.76+0.09%
    $MDT90.76+0.09%
    $MDT90.76+0.09%
    $MDT90.76+0.09%
    $LMAT82.13-0.86%
    $MDT90.76+0.09%
    $PFE26.31-1.16%
    $BSX51.55+0.70%